Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer

Ann Oncol. 1992 Jan;3(1):83-4. doi: 10.1093/oxfordjournals.annonc.a058081.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary
  • Drug Evaluation
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / secondary
  • Male
  • Middle Aged
  • Sulfonylurea Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Sulfonylurea Compounds
  • sulofenur